China Medical Robot Industry Report, 2014-2018
  • Oct.2015
  • Hard Copy
  • USD $1,850
  • Pages:68
  • Single User License
    (PDF Unprintable)       
  • USD $1,700
  • Code: ZYM069
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,600
  • Hard Copy + Single User License
  • USD $2,050
      

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments.

Due to the relatively low technical barriers, numerous companies such as Ekso Bionics (the United States), ReWalk (Israel), Robotics (New Zealand), Rex Bionics (New Zealand) and Cyberdyne (Japan) have got into the field of rehabilitation robots. However, the global surgical robot market is mainly occupied by the US-based Intuitive Surgical, who had sold out 3,266 Da Vinci surgical robots by the end of 2014. Thanks to high technical barriers, high costs, supporting supplies, training of doctors and other factors, Da Vinci surgical robots featured with preemptive advantages will still master the absolute leadership in the long run.

Although China did not start research on medical robots late, it is backward in terms of the development, and is currently dependent on imported surgical robots. By the end of 2014, 24 Chinese hospitals had imported 29 surgeries robots which accomplished 11,651 surgeries cumulatively (5,116 in 2014). In accordance with examination and approval of National Health and Family Planning Commission of China, China will import a total of at least 54 surgical robots which are expected to complete 20,000 surgeries by the end of 2015.

However, China has also made some progress in local surgical robots. For example, the minimally invasive surgical robot system “Smart S” developed by Tianjin University and Smart Robot Technology Group jointly has entered clinical stages; HIT Robot Institute (affiliated companies: Boshi Automation and Harbin Sizherui) expects to apply for testing of its minimally invasive celiac surgical robot system in the form of product testing at the end of 2015, and apply for registration at the end of 2017. Therefore, commercial local surgical robots may emerge in the Chinese market in 2018.

Although China's local surgical robot industrialization develops slowly, many companies, such as Jimho Robot (Shanghai), Shenzhen Mai Kangxin Medical and Anyang SF Robot, have realized prototypes of rehabilitation robots or industrialization promotion. In addition, listed companies including Shenyang SIASUN, Jinming Machinery (Guangdong), Truking Technology and Midea Group have embarked on the layout of the industry.

Given China's intensified aging trend and huge base of physical disability, Chinese rehabilitation robot market may value RMB10 billion potentially. Chinese local rehabilitation robots with price and regional advantages will seize higher market shares in the future.

? 医疗机器人 英文_副本.png

The report includes the following aspects:
20120114.gifOperating environments of Chinese medical robots, including international market environments and domestic policies;
20120114.gifStatus quo, competition pattern and market segments (rehabilitation robots and surgical robots) of China medical robot industry;
20120114.gifOperation, medical robot business and development prospect of 5 overseas and 10 Chinese medical robot companies.

1.Overview of Medical Robotics
1.1 Definition 
1.1.1 Robotics
1.1.2 Medical Robotics
1.2 Industry Chain

2. Analysis on Operation Environment of Medical Robotics in China
2.1 Global Market Overview 
2.1.1 State Quo
2.1.2 Competition Pattern
2.2 Policies 

3. Medical Robotics in China 
3.1 Overview 
3.2 Rehabilitation Medical Robotics 
3.2.1 Increasingly-intensified Aging Trend
3.3.2 Huge Disabled Population 
3.3 Surgical Robotics

4. Major Medical Robotics Companies Worldwide 
4.1 Intuitive Surgical, Inc.
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure  
4.1.4 Gross Margin 
4.1.5 R&D
4.2 Stryker Corporation
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 R&D
4.2.6 Medical Robotics Business 
4.3 Ekso Bionics Holdings, Inc.
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D
4.4 ReWalk Roboticsics Ltd.
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D
4.5 Rex Bionics Plc

5. Major Medical Robotics Enterprises in China
5.1 Shenyang SIASUN Robot & Automation Co., Ltd.
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Medical Robotics Business 
5.1.6 Development Prospect & Forecast 
5.2 Jinming Machinery (Guangdong) Co., Ltd.
5.2.1 Profile
5.2.2 Operation
5.2.3 Medical Robotics Business
5.3 Midea Group Co., Ltd. 
5.3.1 Profile
5.3.2 Operation
5.3.3 Medical Robotics Business
5.4 Truking Technology Limited
5.4.1 Profile
5.4.2 Operation
5.4.3 Medical Robotics Business
5.5 Harbin Boshi Automation Co., Ltd.  
5.5.1 Profile
5.5.2 Operation
5.5.3 Medical Robotics Business
5.6 Chongqing Dima Industry Co., Ltd.
5.6.1 Profile
5.6.2 Operation
5.6.3 Medical Robotics Business
5.7 Other  
5.7.1 Smart Robot Technology Group Co., Ltd.
5.7.2 Jimho Robot (Shanghai) Co., Ltd.
5.7.3 Shenzhen Mai Kangxin Medical Co., Ltd.
5.7.4 Anyang SF Robot Co., Ltd. 
Classification of Medical Robotics and Major Companies 
Cost Structure of Medical Robotics 
Medical Robotics Industry Development Plans of Major Countries 
Sales Volume of Professional Service Robotics and YoY Growth Worldwide, 2009-2014 
Proportion of Global Professional Service Robotics (by Sales Volume)
Sales Volume of Medical Robotics and YoY Growth Worldwide, 2009-2014
Global Surgical Robotics Market Size, 2014/2020E
Global Rehabilitation Robotics Market Size, 2014/2020E
China’s Plans on Robotics Industry, 2010-2015
Robotics Industry Parks in China and Planning Goal, 2014-2015
Major Medical Robotics Research Institutions/Companies in China and Their Products 
65-year-old (or above) Population in China and % in Total, 2009-2014
15 to 64-year-old Population’s Proportion in Total of China, 2009-2014 
Average Family Size in China, 2009-2014E
Disabled Population’ Proportion in China’s Total by Type, 2010
Disposable Income of Urban and Rural Disabled Persons in China, 2007-2013
Engel Coefficient of Urban and Rural Disabled Persons in China, 2007-2013
Urban Disabled Persons’ Medical Healthcare Expenditures in China and % in Consumer Spending, 2007-2013
Rural Disabled Persons’ Medical Healthcare Expenditures in China and % in Consumer Spending, 2007-2013
Medical Robotics Configuration in Hospitals of Chinese Mainland, 2014
Quantity of Planned Medical Robotics in Hospitals of Chinese Mainland, 2015-2016E
Revenue and Net Income of Intuitive Surgical, 2010-2015
System Placements of da Vinci Surgical System, 2013-2014
Systems Placement Mix of da Vinci Surgical System, 2014
System Placements of da Vinci Surgical System by Region, 2014
Surgical Operation Quantity of da Vinci Surgical System by Type, 2009-2015
Revenue of Intuitive Surgical by Product, 2012-2014
Gross Margin of Intuitive Surgical, 2010-2015
R&D Costs and % of Total Revenue of Intuitive Surgical, 2012-2015
Revenue and Net Income of Stryker, 2009-2015
Revenue of Stryker by Product, 2009-2015
Repair Products’ Revenue Breakdown of Stryker by Application, 2011-2015
Medical System’s Revenue Breakdown of Stryker by Application, 2011-2015
Neural Technology & Spine Business’s Revenue Breakdown of Stryker by Application, 2011-2015
Gross Margin of Stryker, 2009-2014
Knee-joint and Hip-joint Systems of Makoplasty
Revenue of Ekso Bionics, 2011-2015
Net Income of Ekso Bionics, 2011-2015
Revenue of Ekso Bionics by Product, 2012-2015
R&D Costs and % of Total Revenue of Ekso Bionics, 2012-2015
Revenue of Rewalk Robotics, 2012-2015
Net Income of Rewalk Robotics, 2012-2015
Revenue of Rewalk Robotics by Region, 2012-2015
R&D Costs and % of Total Revenue of Rewalk Robotics, 2012-2015
Operation of SIASUN’s Major Subsidiaries, 2014
Revenue and Net Income of SIASUN, 2008-2015
Revenue of SIASUN by Product, 2010-2015
Operating Revenue of SIASUN by Region, 2010-2014
Gross Margin of SIASUN by Product, 2010-2014
Revenue and Gross Profit of SIASUN’s Industrial Robot Business, 2009-2014
Revenue and Net Income of Jinming Machinery, 2010-2015
Gross Margin of Jinming Machinery, 2010-2015
Revenue of Jinming Machinery by Product, 2010-2015
Research Direction of Jinming Machinery and Tsinghua University’s Joint Research Center 
Revenue and Net Income of Midea Group, 2012-2015
Gross Margin of Midea Group, 2012-2015
Revenue of Midea Group by Product, 2012-2015
Midea’s Subsidiaries Involving Robotics Business  
Revenue and Net Income of Truking Technology, 2010-2015
Gross Margin of Truking Technology, 2010-2015
Revenue of Truking Technology by Product, 2010-2015 
Revenue and Net Income of Boshi Automation, 2010-2015
Gross Margin of Boshi Automation, 2010-2015
Revenue of Boshi Automation by Product, 2010-2015
Revenue and Net Income of Dima Industry, 2010-2015
Gross Margin of Dima Industry, 2010-2015
Revenue of Dima Industry by Product, 2010-2015

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

China Aged Care Industry Report, 2014-2017

According to the UN standard (the elderly people aged over 60 accounting for 10% of total population or the elderly people over age 65 occupying 7% of total population in one region), China entered th...

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统